in

Metropolis Healthcare To Achieve 15% Revenue Growth For FY25 Led By Stronger Q4 Trends: CEO

Talking about the acquisition of Core Diagnostics that the company had earlier announced, its CEO mentioned there would be some margin erosion due to it. This is because Core Diagnostics operates at a lower margin than Metropolis Healthcare.

“Yes (margins will dilute). But the Core Diagnostic…

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Why the RBI may cut interest rates by 25 basis points on Friday

stock picks: 2 top stock recommendations from Rahul Sharma